Prostate Cancer Market Research Reports

Prostate Cancer Market Research

Incidences of cancer afflictions have rapidly increased in recent years, while efforts are still underway to find a ... view more

RSS Sort By :
TITLE Price Buy Now More options

This report studies the global Prostate Cancer Drugs market, analyzes and researches the Prostate Cancer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top player...

$ 3300


This study focuses on China’s Prostate Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consu...

$ 1800


China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the c...

$ 4000


This study focuses on China’s Prostate Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in Chi...

$ 1800


This report studies Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Global market, especially in North America, Europe, China, Japan, Latin America and India, focuses on top manufacturers in global market, with capacity, production,...

$ 2999


Notes: Sales, means the sales volume of Drugs for Prostate Cancer Revenue, means the sales value of Drugs for Prostate Cancer This report studies Drugs for Prostate Cancer in China market, focuses on the top players in Ch...

$ 3200


Notes: Sales, means the sales volume of Drugs for Prostate Cancer Revenue, means the sales value of Drugs for Prostate Cancer This report studies sales (consumption) of Drugs for Prostate Cancer in Europe market, especial...

$ 3900


Notes: Sales, means the sales volume of Drugs for Prostate Cancer Revenue, means the sales value of Drugs for Prostate Cancer This report studies sales (consumption) of Drugs for Prostate Cancer in United States market, f...

$ 3800


Notes: Sales, means the sales volume of Drugs for Prostate Cancer Revenue, means the sales value of Drugs for Prostate Cancer This report studies sales (consumption) of Drugs for Prostate Cancer in Global market, especial...

$ 4000


Notes: Production, means the output of Drugs for Prostate Cancer Revenue, means the sales value of Drugs for Prostate Cancer This report studies Drugs for Prostate Cancer in Global market, especially in North America, Eur...

$ 2900


Xtandi – Replacing competitor from Zytiga to Casodex (Bicalutamide) for a  bigger pie in Prostate cancer & Finding its niche in crowded BC market Xtandi + Zytiga vs.  ARN-509 + Zytiga   -   Who will win the ...

$ 4500


Notes: Production, means the output of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, means the sales value of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics This report studies Ca...

$ 2900


Notes: Production, means the output of Prostate Cancer Revenue, means the sales value of Prostate Cancer This report studies Prostate Cancer in Global market, especially in North America, Europe, China, Japan, Southeast A...

$ 2900


DelveInsight’s Prostate cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy...

$ 4950


DelveInsight’s Report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Pha...

$ 2000


DelveInsight’s Report, “Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug...

$ 2000


DelveInsight’s Report, “Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacro...

$ 2000


DelveInsight’s Report, “Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the glob...

$ 2000


DelveInsight “Prostate cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Prostate cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical a...

$ 2750


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.Prostate cancer is a form of cancer that affe...

$ 2500

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: